查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
南美洲和中美洲干细胞治疗市场预测至 2028 年 - 区域分析 - 按类型、治疗、应用和最终用户
市场调查报告书
商品编码
1402732

南美洲和中美洲干细胞治疗市场预测至 2028 年 - 区域分析 - 按类型、治疗、应用和最终用户

South & Central America Stem Cell Therapy Market Forecast to 2028 - Regional Analysis - by Type, Treatment, Application, and End User
出版日期: | 出版商: The Insight Partners | 英文 120 Pages | 订单完成后即时交付

价格

南美洲和中美洲干细胞疗法预计将从2022年的7,516万美元成长到2028年的1.393亿美元。预计2022年至2028年CAGR为10.8%。

诱导多能干细胞在再生医学的使用推动了南美洲和中美洲干细胞治疗市场

根据 Frontiers Media SA 2023 报告，诱导多能干细胞 (iPSC) 领域的进展为治疗学研究开闢了新的途径。 iPSC 主要用于疾病建模、再生医学和药物发现/药物细胞毒性研究等研究和临床研究。例如，iPSC 可用于将分化的体细胞转化为多能干细胞，以产生成体组织的不同细胞类型。因此，iPSC 在再生医学中显示出有希望的结果，特别是在替换患病或受伤的细胞方面。 iPSC 广泛用于再生组织特异性细胞，用于移植到患者体内以治疗损伤和退化性疾病。涉及小分子筛选的药物发现和用于安全评估的毒性测试等研究已成功揭露基于 iPSC 的正面结果。上述因素预计将在未来几年为南美洲和中美洲干细胞治疗市场的公司提供利润丰厚的成长机会。

南美洲和中美洲干细胞治疗概述

巴西政府和医疗机构正在实施建设性策略，以提高各国对干细胞疗法的认识和接触。例如，为了提供国际曝光，当局正专注于在国内进行临床试验。例如，根据 ClinicalTrials.gov 的数据，2016 年，该国正在进行约 27 项干细胞研究，估计占全球所有干细胞研究的 1.7%。此外，国家在进入干细胞领域之初就拨款约500万美元用于干细胞研究。该国意识的提高正在推动干细胞市场创新和发现的成长。例如，2017 年，巴西新创公司 R-Crio 发现了一种从一颗乳牙产生约 700 万个干细胞的方法。这些因素可能会在预测期内推动巴西干细胞治疗市场的成长。

南美洲和中美洲干细胞治疗收入及 2028 年预测（百万美元）

南美洲和中美洲干细胞治疗细分

南美洲和中美洲干细胞疗法分为类型、治疗、应用、最终用户和国家。

根据类型，南美洲和中美洲干细胞疗法分为成体干细胞疗法、胚胎干细胞疗法、诱导性多能干细胞疗法和其他干细胞疗法。 2022年，成体干细胞治疗领域在南美洲和中美洲干细胞治疗中占据最大份额。成体干细胞治疗细分为造血干细胞治疗、脐带干细胞治疗、神经元干细胞治疗及间质干细胞治疗。

根据治疗方式，南美洲和中美洲干细胞疗法分为同种异体和自体干细胞疗法。 2022年，同种异体部分在南美洲和中美洲干细胞治疗中占据更大份额。

根据应用，南美洲和中美洲干细胞疗法分为肌肉骨骼、皮肤病学、心臟病学、药物发现和开发以及其他应用。 2022年，肌肉骨骼领域在南美洲和中美洲干细胞治疗中占据最大份额。

根据最终用户，南美洲和中美洲干细胞疗法分为医院和专科诊所以及学术和研究机构。 2022年，学术和研究机构部门在南美洲和中美洲干细胞治疗中占据了更大的份额。

根据国家/地区，南美洲和中美洲干细胞治疗分为巴西、阿根廷以及南美洲和中美洲其他地区。 2022年，巴西市场在南美洲和中美洲干细胞治疗领域占据最大份额。

Lonza Group AG、Pluri Inc、Smith & Nephew Plc 和 TiGenix NV（武田製药有限公司）是南美洲和中美洲干细胞治疗领域的一些领先公司。

目录

第 1 章：简介

  • 研究范围
  • Insight Partners 研究报告指南
  • 市场区隔
    • 南美洲和中美洲干细胞治疗市场 - 按类型
    • 南美洲和中美洲干细胞治疗市场 - 按治疗分类
    • 南美洲和中美洲干细胞治疗市场 -按应用
    • 南美洲和中美洲干细胞治疗市场 - 按最终用户
    • 南美洲和中美洲干细胞治疗市场 - 按国家/地区

第 2 章：南美洲和中美洲干细胞治疗市场 - 要点

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：南美洲和中美洲干细胞治疗市场 - 市场模式

  • 概述
  • 南美洲和中美洲 PEST 分析
  • 专家意见

第 5 章：南美洲和中美洲干细胞治疗市场 - 主要市场动态

  • 市场驱动因素
    • 增加与干细胞治疗相关的研究活动以实现有效的疾病管理
    • 癌症盛行率不断上升
  • 市场限制
    • 核准的治疗费用高昂
  • 市场机会
    • 诱导多能干细胞在再生医学的应用
  • 未来的趋势
    • 研究活动和产品创新
  • 影响分析

第 6 章：干细胞治疗市场 - 南美洲和中美洲分析

  • 南美洲和中美洲干细胞治疗市场收入预测与分析

第 7 章：南美洲和中美洲干细胞治疗市场 - 2028 年收入和预测 - 按类型

  • 概述
  • 南美洲和中美洲干细胞治疗市场收入份额，按类型 2021 年和 2028 年 (%)
  • 成体干细胞治疗
  • 胚胎干细胞治疗
  • 诱导性多能干细胞疗法
  • 其他干细胞疗法

第 8 章：南美洲和中美洲干细胞治疗市场分析和 2028 年预测 - 按治疗方法

  • 概述
  • 南美洲和中美洲干细胞治疗市场，依治疗方法划分 2021 年和 2028 年 (%)
  • 同种异体
  • 自体

第 9 章：南美洲和中美洲干细胞治疗市场分析及 2028 年预测 -按应用

  • 概述
  • 南美洲和中美洲干细胞治疗市场，按应用划分 2021 年和 2028 年（%）
  • 肌肉骨骼
  • 皮肤科
  • 心臟病学
  • 药物发现与开发
  • 其他应用

第 10 章：南美洲和中美洲干细胞治疗市场 - 收入和 2028 年预测 - 按最终用户

  • 概述
  • 2021 年和 2028 年南美洲和中美洲干细胞治疗市场收入份额（按最终用户划分）（%）
  • 学术及研究机构
  • 医院和专科诊所

第 11 章：南美洲和中美洲干细胞治疗市场 - 2028 年收入和预测 - 国家分析

    • 南美洲和中美洲
      • 巴西
      • 阿根廷
      • 南美洲和中美洲其他地区

第 12 章：南美洲和中美洲干细胞治疗市场-产业格局

  • 概述
  • 有机发展
    • 概述
  • 无机发展
    • 概述

第 13 章：公司简介

  • TiGenix NV (Takeda Pharmaceutical Company Limited)
  • NuVasive Inc
  • Lonza Group AG
  • Smith & Nephew Plc

第 14 章：附录

  • 关于 Insight Partners
  • 专业术语
Product Code: BMIRE00029077

The South & Central America stem cell therapy is expected to grow from US$ 75.16 million in 2022 to US$ 139.30 million by 2028. It is estimated to grow at a CAGR of 10.8% from 2022 to 2028.

Use of Induced Pluripotent Stem Cells in Regenerative Medicines Drives South & Central America Stem Cell Therapy Market

Per the Frontiers Media S.A. 2023 report, progress in the field of induced pluripotent stem cells (iPSCs) has opened a new gateway for research in therapeutics. iPSCs are mainly intended for research and clinical studies such as disease modeling, regenerative medicine, and drug discovery/drug cytotoxicity studies. For example, iPSCs can be used to convert differentiated somatic cells to multipotent stem cells to generate different cell types of adult tissues. Thus, iPSCs have shown promising results in regenerative medicine, particularly for replacing diseased or injured cells. iPSCs are widely used to regenerate tissue-specific cells for transplantation in patients for treating injuries and degenerative diseases. Studies such as drug discovery involving screening of small molecules and toxicity testing for safety assessment have been successfully disclosed positive iPSCs-based results. The aforementioned factors are expected to offer lucrative growth opportunities to companies in the South & Central America stem cell therapy market in the coming years.

South & Central America Stem Cell Therapy Overview

The government and healthcare authorities in Brazil are implementing constructive strategies to increase the awareness and exposure of stem cell therapies in the countries. For example, providing international exposure, the authorities are focusing on conducting clinical trials in the country. For instance, according to clinicaltrials.gov, in 2016, around 27 stem cell studies were being conducted in the country, which accounted for an estimated 1.7% of all the stem cell studies across the globe. Also, the country allotted around US$ 5.0 Mn for stem cell research at the starting beginning of the entry in the stem cell domain. Increasing awareness in the country is fueling the growth of innovations and discoveries in the stem cell market. For instance, in 2017, R-Crio, a Brazil-based startup, discovered a way to produce around 7 million stem cells from a single baby tooth. These factors are likely to drive the growth of the Brazil stem cell therapy market during the forecast period.

South & Central America Stem Cell Therapy Revenue and Forecast to 2028 (US$ Million)

South & Central America Stem Cell Therapy Segmentation

The South & Central America stem cell therapy is segmented into type, treatment, application, end user, and country.

Based on type, the South & Central America stem cell therapy is segmented into adult stem cell therapy, embryonic stem cell therapy, induced pluripotent stem cell therapy, and other stem cell therapy. In 2022, the adult stem cell therapy segment registered the largest share in the South & Central America stem cell therapy. The adult stem cell therapy segments is further segmented into hematopoietic stem cell therapy, umbilical cord stem cell therapy, neuronal stem cell therapy, and mesenchymal stem cell.

Based on treatment, the South & Central America stem cell therapy is bifurcated into allogeneic and autologous. In 2022, the allogeneic segment registered a larger share in the South & Central America stem cell therapy.

Based on application, the South & Central America stem cell therapy is segmented into musculoskeletal, dermatology, cardiology, drug discovery & development, and other applications. In 2022, the musculoskeletal segment registered the largest share in the South & Central America stem cell therapy.

Based on end user, the South & Central America stem cell therapy is bifurcated into hospitals & specialty clinics and academic & research institutes. In 2022, the academic & research institutes segment registered a larger share in the South & Central America stem cell therapy.

Based on country, the South & Central America stem cell therapy is segmented into Brazil, Argentina, and the Rest of South & Central America. In 2022, Brazil segment registered the largest share in the South & Central America stem cell therapy.

Lonza Group AG, Pluri Inc, Smith & Nephew Plc, and TiGenix NV (Takeda Pharmaceutical Company Limited) are some of the leading companies operating in the South & Central America stem cell therapy.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America stem cell therapy market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the South & Central America stem cell therapy market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the stem cell therapy market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 South & Central America Stem Cell Therapy Market - By Type
    • 1.3.2 South & Central America Stem Cell Therapy Market - By Treatment
    • 1.3.3 South & Central America Stem Cell Therapy Market - By Application
    • 1.3.4 South & Central America Stem Cell Therapy Market - By End User
    • 1.3.5 South & Central America Stem Cell Therapy Market - By Country

2. South & Central America Stem Cell Therapy Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. South & Central America Stem Cell Therapy Market- Market Landscape

  • 4.1 Overview
  • 4.2 South & Central America PEST Analysis
  • 4.3 Experts Opinion

5. South & Central America Stem Cell Therapy Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Research Activities Related to Stem Cell Therapy for Effective Disease Management
    • 5.1.2 Growing Prevalence of Cancer
  • 5.2 Market Restraints
    • 5.2.1 High Cost of Approved Treatments
  • 5.3 Market Opportunities
    • 5.3.1 Use of Induced Pluripotent Stem Cells in Regenerative Medicines
  • 5.4 Future Trends
    • 5.4.1 Research Activities and Product Innovations
  • 5.5 Impact Analysis

6. Stem Cell Therapy Market - South & Central America Analysis

  • 6.1 South & Central America Stem Cell Therapy Market Revenue Forecast and Analysis

7. South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 - by Type

  • 7.1 Overview
  • 7.2 South & Central America Stem Cell Therapy Market Revenue Share, by Type 2021 & 2028 (%)
  • 7.3 Adult Stem Cell Therapy
    • 7.3.1 Overview
    • 7.3.2 Adult Stem Cell Therapy: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
    • 7.3.3 Hematopoietic Stem Cell Therapy
      • 7.3.3.1 Overview
      • 7.3.3.2 Hematopoietic Stem Cell Therapy: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
    • 7.3.4 Umbilical Cord Stem Cell Therapy
      • 7.3.4.1 Overview
      • 7.3.4.2 Umbilical Cord Stem Cell Therapy: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
    • 7.3.5 Neuronal Stem Cell Therapy
      • 7.3.5.1 Overview
      • 7.3.5.2 Neuronal Stem Cell Therapy: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
    • 7.3.6 Mesenchymal Stem Cell
      • 7.3.6.1 Overview
      • 7.3.6.2 Mesenchymal Stem Cell: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Embryonic Stem Cell Therapy
    • 7.4.1 Overview
    • 7.4.2 Embryonic Stem Cell Therapy: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.5 Induced Pluripotent Stem Cell Therapy
    • 7.5.1 Overview
    • 7.5.2 Induced Pluripotent Stem Cell Therapy: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.6 Other Stem Cell Therapy
    • 7.6.1 Overview
    • 7.6.2 Other Stem Cell Therapy: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)

8. South & Central America Stem Cell Therapy Market Analysis and Forecasts to 2028 - by Treatment

  • 8.1 Overview
  • 8.2 South & Central America Stem Cell Therapy Market, by Treatment 2021 & 2028 (%)
  • 8.3 Allogeneic
    • 8.3.1 Overview
    • 8.3.2 Allogeneic: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Autologous
    • 8.4.1 Overview
    • 8.4.2 Autologous: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)

9. South & Central America Stem Cell Therapy Market Analysis and Forecasts to 2028 - by Application

  • 9.1 Overview
  • 9.2 South & Central America Stem Cell Therapy Market, by Application 2021 & 2028 (%)
  • 9.3 Musculoskeletal
    • 9.3.1 Overview
    • 9.3.2 Musculoskeletal: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Dermatology
    • 9.4.1 Overview
    • 9.4.2 Dermatology: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Cardiology
    • 9.5.1 Overview
    • 9.5.2 Cardiology: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.6 Drug Discovery and Development
    • 9.6.1 Overview
    • 9.6.2 Drug Discovery and Development: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.7 Other Applications
    • 9.7.1 Overview
    • 9.7.2 Other Applications: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)

10. South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 - by End User

  • 10.1 Overview
  • 10.2 South & Central America Stem Cell Therapy Market Revenue Share, by End User 2021 & 2028 (%)
  • 10.3 Academic & Research Institutes
    • 10.3.1 Overview
    • 10.3.2 Academic & Research Institutes: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
  • 10.4 Hospitals & Specialty Clinics
    • 10.4.1 Overview
    • 10.4.2 Hospitals & Specialty Clinics: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)

11. South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 - Country Analysis

  • 11.1 Overview
    • 11.1.1 South and Central America: Stem Cell Therapy Market, by Country, 2021 & 2028(%)
      • 11.1.1.1 Brazil: Stem Cell Therapy Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.1.1.1 Brazil: Stem Cell Therapy Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.1.1.2 Brazil: Stem Cell Therapy Market, by Type, 2019-2028 (USD Million)
        • 11.1.1.1.2.1 Brazil: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019-2028 (USD Million)
        • 11.1.1.1.3 Brazil: Stem Cell Therapy Market, by Treatment, 2019-2028 (USD Million)
        • 11.1.1.1.4 Brazil: Stem Cell Therapy Market, by Application, 2019-2028 (USD Million)
        • 11.1.1.1.5 Brazil: Stem Cell Therapy Market, by End User , 2019-2028 (USD Million)
      • 11.1.1.2 Argentina: Stem Cell Therapy Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.1.2.1 Argentina: Stem Cell Therapy Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.1.2.2 Argentina: Stem Cell Therapy Market, by Type, 2019-2028 (USD Million)
        • 11.1.1.2.2.1 Argentina: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019-2028 (USD Million)
        • 11.1.1.2.3 Argentina: Stem Cell Therapy Market, by Treatment, 2019-2028 (USD Million)
        • 11.1.1.2.4 Argentina: Stem Cell Therapy Market, by Application, 2019-2028 (USD Million)
        • 11.1.1.2.5 Argentina: Stem Cell Therapy Market, by End User , 2019-2028 (USD Million)
      • 11.1.1.3 Rest of South and Central America: Stem Cell Therapy Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.1.3.1 Rest of South and Central America: Stem Cell Therapy Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.1.3.2 Rest of South and Central America: Stem Cell Therapy Market, by Type, 2019-2028 (USD Million)
        • 11.1.1.3.2.1 Rest of South and Central America: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019-2028 (USD Million)
        • 11.1.1.3.3 Rest of South and Central America: Stem Cell Therapy Market, by Treatment, 2019-2028 (USD Million)
        • 11.1.1.3.4 Rest of South and Central America: Stem Cell Therapy Market, by Application, 2019-2028 (USD Million)
        • 11.1.1.3.5 Rest of South and Central America: Stem Cell Therapy Market, by End User , 2019-2028 (USD Million)

12. South & Central America Stem Cell Therapy Market-Industry Landscape

  • 12.1 Overview
  • 12.2 Organic Developments
    • 12.2.1 Overview
  • 12.3 Inorganic Developments
    • 12.3.1 Overview

13. Company Profiles

  • 13.1 TiGenix NV (Takeda Pharmaceutical Company Limited)
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 NuVasive Inc
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Lonza Group AG
    • 13.3.1 Business Description
    • 13.3.2 Products and Services
    • 13.3.3 Financial Overview
    • 13.3.4 SWOT Analysis
    • 13.3.5 Key Developments
  • 13.4 Smith & Nephew Plc
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. Brazil Stem Cell Therapy Market, by Type - Revenue and Forecast to 2028 (USD Million)
  • Table 2. Brazil Stem Cell Therapy Market, by Adult Stem Cell Therapy - Revenue and Forecast to 2028 (USD Million)
  • Table 3. Brazil Stem Cell Therapy Market, by Treatment - Revenue and Forecast to 2028 (USD Million)
  • Table 4. Brazil Stem Cell Therapy Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 5. Brazil Stem Cell Therapy Market, by End-User - Revenue and Forecast to 2028 (USD Million)
  • Table 6. Argentina Stem Cell Therapy Market, by Type - Revenue and Forecast to 2028 (USD Million)
  • Table 7. Argentina Stem Cell Therapy Market, by Adult Stem Cell Therapy - Revenue and Forecast to 2028 (USD Million)
  • Table 8. Argentina Stem Cell Therapy Market, by Treatment - Revenue and Forecast to 2028 (USD Million)
  • Table 9. Argentina Stem Cell Therapy Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 10. Argentina Stem Cell Therapy Market, by End-User - Revenue and Forecast to 2028 (USD Million)
  • Table 11. Rest of South and Central America Stem Cell Therapy Market, by Type - Revenue and Forecast to 2028 (USD Million)
  • Table 12. Rest of South and Central America Stem Cell Therapy Market, by Adult Stem Cell Therapy - Revenue and Forecast to 2028 (USD Million)
  • Table 13. Rest of South and Central America Stem Cell Therapy Market, by Treatment - Revenue and Forecast to 2028 (USD Million)
  • Table 14. Rest of South and Central America Stem Cell Therapy Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 15. Rest of South and Central America Stem Cell Therapy Market, by End-User - Revenue and Forecast to 2028 (USD Million)
  • Table 16. Organic Developments in the South & Central America stem cell therapy market
  • Table 17. Inorganic Developments in the South & Central America stem cell therapy market
  • Table 18. Glossary of Terms

List Of Figures

  • Figure 1. South & Central America Stem Cell Therapy Market Segmentation
  • Figure 2. South & Central America Stem Cell Therapy Segmentation, By Country
  • Figure 3. South & Central America Stem Cell Therapy Market Overview
  • Figure 4. Adult Stem Cell Therapy Segment Held Largest Share of Type Segment in South & Central America Stem Cell Therapy Market
  • Figure 5. Brazil Is Expected to Show Remarkable Growth During the Forecast Period
  • Figure 6. South & Central America (SCAM) PEST Analysis
  • Figure 7. Experts Opinion
  • Figure 8. South & Central America Stem Cell Therapy Market Impact Analysis of Drivers and Restraints
  • Figure 9. South & Central America Stem Cell Therapy Market - Revenue Forecast and Analysis - 2020- 2028
  • Figure 10. South & Central America Stem Cell Therapy Market Revenue Share, by Type 2021 & 2028 (%)
  • Figure 11. Adult Stem Cell Therapy: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 12. Hematopoietic Stem Cell Therapy: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 13. Umbilical Cord Stem Cell Therapy: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 14. Neuronal Stem Cell Therapy: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 15. Mesenchymal Stem Cell: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 16. Embryonic Stem Cell Therapy: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 17. Induced Pluripotent Stem Cell Therapy: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 18. Other Stem Cell Therapy: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 19. South & Central America Stem Cell Therapy Market, by Treatment 2021 & 2028 (%)
  • Figure 20. Allogeneic: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 21. Autologous: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. South & Central America Stem Cell Therapy Market, by Application 2021 & 2028 (%)
  • Figure 23. Musculoskeletal: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 24. Dermatology: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. Cardiology: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 26. Drug Discovery and Development: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 27. Other Applications: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 28. Stem Cell Therapy Market Revenue Share, by End User 2021 & 2028 (%)
  • Figure 29. Academic & Research Institutes: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 30. Hospitals & Specialty Clinics: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 31. South and Central America Stem Cell Therapy Market, by Key Country - Revenue (2021) (USD Million)
  • Figure 32. South and Central America: Stem Cell Therapy Market, by Country, 2021 & 2028 (%)
  • Figure 33. Brazil: Stem Cell Therapy Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 34. Argentina: Stem Cell Therapy Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 35. Rest of South and Central America: Stem Cell Therapy Market - Revenue and Forecast to 2028 (USD Million)